Company: GNOLF
Filing Date: 2025-05-01
Form Type: 20-F/A
Source: 0001654954-25-004987
Chunk: 3

Company: GENOIL INC
Filing Date: 2025-05-01
Form: 20-F/A
Chunk 3
---
| Item 14. | Material Modifications to the Rights of Security Holders and Use of Proceeds. |     | 30 |
| Item 15. | Controls and Procedures.                                                      |     | 30 |
| Item 16. | [Reserved]                                                                    |     | 31 |
|          | Item A Audit Committee Financial Expert                                       |     | 31 |
|          | Item B Code of Ethics.                                                        |     | 31 |
|          | Item C Audit Fees.                                                            |     | 32 |
|          | Item E Share Repurchases                                                      |     | 33 |
|          | Item I Disclosure Regarding Foreign Jurisdictions that Prevent Inspections    |     | 33 |
|          | Item J Insider Trading Policies                                               |     | 33 |
|          | Item K Cybersecurity                                                          |     | 33 |
| Item 17. | Financial Statements.                                                         |     | 34 |
| Item 19. | Exhibits.                                                                     |     | 34 |

| 2 |

<div align='center'>PART I</div>

Item 1. Identity of Directors, Senior Management and Advisers

A.Directors and senior management.

Not required as this is an annual report under the Exchange Act.

B.Advisers.

Not required as this is an annual report under the Exchange Act.

C.Auditors.

Not required as this is an annual report under the Exchange Act.

Item 2. Offer Statistics and Expected Timetable

Not required as this is an annual report under the Exchange Act.

Item 3. Key Information

A.[Reserved]

B.Capitalization and indebtedness.

Not required as this is an annual report under the Exchange Act.

C. Reasons for the offer and use of proceeds.

Not required as this is an annual report under the Exchange Act.

D. Risk factors.

Going Concern

To date Genoil has not attained commercially viable operations from its various patents and technology rights.

The ability of the Company to continue as a going concern is dependent on commercializing its technologies, achieving profitable operations and obtaining the necessary financing in order to develop these technologies further. The outcome of these matters cannot be predicted at this time. The Company will continue to review the prospects of raising additional debt and equity financing to support its operations until such time that its operations become self-sustaining, to fund its research and development activities and to ensure the realization of its assets and discharge of its liabilities. While the Company is expending its best efforts to achieve the above plans, there is no